Magnetic Resonance Spectroscopy of cancer - Practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma

European Journal of Cancer

Volumn 38, Issue 16, 2002, Pages 2085-2093

  Griffiths, J R ^a   Tate, A R ^a   Howe, F A ^a   Stubbs, M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

31P MRS, Non Hodgkin's lymphoma; Cancer; Clinical trial; Decoupling; Magnetic Resonance Spectroscopy; NTP; Phosphomonoesters; Quality control; RF coils; Treatment response

Indexed keywords

ANTINEOPLASTIC AGENT; ESTER DERIVATIVE; NUCLEOTIDE DERIVATIVE; PHOSPHATE; PHOSPHORUS DERIVATIVE;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CLINICAL TRIAL; CORRELATION ANALYSIS; HUMAN; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PATIENT MONITORING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; RADIOFREQUENCY; REVIEW; SOLID TUMOR; TREATMENT FAILURE;

CLINICAL PROTOCOLS; CLINICAL TRIALS; EQUIPMENT DESIGN; HUMANS; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE IMAGING; MULTICENTER STUDIES; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0036840705     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00389-1     Document Type: Article

References (23)

1. Howe FA. Magnetic resonance spectroscopy in vivo. In MRI: Principles and Clinical Applications, Stamford, CT, USA, Appleton and Lange, 1998.
2. Tate A.R., Griffiths J.R., Martinez-Perez I.et al. Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed. 11:1998;177-191.
3. Preul M.C., Caramanos Z., Collins D.L.et al. Accurate, non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med. 2:1996;323-325.
4. Negendank W. Studies of human tumors by MRS. a review NMR Biomed. 5:1992;303-324.
5. Negendank W.G., Padavic-Shaller K.A., Li C.-W.et al. Metabolic characterisation of Non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 55:1995;3286-3294.
6. Findlay M.P., Leach M.O. In vivo monitoring of fluoropyrimidine metabolites. magnetic resonance spectroscopy in the evaluation of 5-fluorouracil. 1994 Anti-Cancer Drugs. 5:1994;260-280.
7. 2) breathing in rats after 5FU treatment. Acta Oncol. 2001, 40, 609-614.
8. Leach M.O., Arnold D., Brown T.R.et al. International workshop on standardization in clinical MRS. proceedings and recommendations Technol. Healthcare. 2:1994;217-234.
9. Negendank W.G., Sauter R., Brown T.R.et al. Proton magnetic resonance spectroscopy in patients with glial tumors. a multicenter study J. Neurosurg. 84:1996;449-458.
10. 1H MR spectroscopy in patients with metastatic brain tumors. a multicentre study Magn. Reson. Med. 33:1995;818-826.
11. Webb P.G., Sailasuta N., Kohler S.J., Raidy T., Moats R.A., Hurd R.E. Automated single-voxel proton MRS. technical development and multisite verification Magn. Reson. Med. 31:1994;365-373.
12. Murphy-Boesch J., Jiang H., Stoyanova R.et al. Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B-1 inhomogeneity. Magn. Reson. Med. 39:1998;429-438.
13. 31P MRS of the head and neck region. Magn. Reson. Imaging. 19:2001;755-759.
14. Garwood M., Ke Y. Symmetric pulses to induce arbitrary flip angles with compensation for RF inhomogeneity and resonance offsets. J. Magn. Reson. 94:1991;511-525.
15. Bottomley P.A., Ouwerkerk R. An improved implementation of low-angle adiabatic (Bir-4) excitation pulses. J. Magn. Reson. A. 103:1993;242-243.
16. Schwarz A.J., Rijpkema M., Collins D.J.et al. SAR and tissue heating with a clinical 31P MRS protocol using surface coils, adiabatic pulses, and proton-decoupling. Magn. Reson. Med. 44:2000;692-700.
17. Ordidge R.J., Connelly A., Lohman J.A.B. Image selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J. Magn. Reson. 66:1986;283-294.
18. Brown T.R., Kincaid B.M., Ugurbil K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA. 79:1982;3523-3526.
19. Doyle V.L., Howe F.A., Griffiths J.R. The effect of respiratory motion on CSI localised MRS. Phys. Med. Biol. 45:2000;1-12.
20. Schwarz A.J., Leach M.O. Implications of respiratory motion for the quantification of 2D MR spectroscopic imaging data in the abdomen. Phys. Med. Biol. 45:2000;2105-2116.
21. Arias-Mendoza F, Brown TR, Charles HC, et al. Methodological standardization for a multi-institutional in vivo trial of localised 31P MR spectroscopy in human cancer research. Proc Int Soc Magn Reson Med 1999, 7, 1585.
22. 31P NMR signals using the variable projection method and prior knowledge. Magn. Reson. Med. 6:1989;92-98.
23. Arias-Mendoza F., Zakian K., Stubbs M.et al. Investigation of the predictive vaue of pre-treatment tumor content of phosphoethanolamine and phosphocholine measured by in vivo 31 P MR spectroscopy in non-Hodgkins lymphoma in a multi institutional setting. Proc. Intl. Soc. Mag. Reson. Med. 9:2001;274.